维普中文期刊产品整合服务
1086篇 您的检索式:作者名="KIM S F"
    题名 作者 年代 出处 被引量
1Hepatocellular carcinoma: Review of disease and tumor biomarkers显示文摘Hepatocellular carcinoma(HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative treatments is limited to early stage cancers, diagnosis in non-symptomatic individuals is crucial. International guidelines advise regular surveillance of high-risk populations but the current tools lack sufficient sensitivity for early stage tumors on the background of a cirrhotic nodular liver. A number of novel biomarkers have now been suggested in the literature, which may reinforce the current surveillance methods. In addition, recent metabonomic and proteomic discoveries have established specific metabolite expressions in HCC, according to Warburg's phenomenon of altered energy metabolism. With clinical validation, a simple and non-invasive test from the serum or urine may be performed to diagnose HCC, particularly benefiting low resource regions where the burden of HCC is highest.Jin Un Kim Mohamed I F Shariff Mary M E Crossey Maria Gomez-Romero Elaine Holmes I Jane Cox Haddy K S Fye Ramou Njie Simon D Taylor-Robinson 2016World Journal of Hepatology2016,8,10:13
2Colonoscopic yield of colorectal neoplasia in daily clinical practice显示文摘AIM:To assess the prevalence and location of ad-vanced neoplasia in patients undergoing colonoscopy,and to compare the yield per indication.METHODS:In a multicenter colonoscopy survey (n = 18 hospitals) in the Amsterdam area (Northern Holland),data of all colonoscopies performed during a three month period in 2005 were analyzed. The location and the histological features of all colonic neoplasia were recorded. The prevalence and the distribution ofadvanced colorectal neoplasia and differences in yield between indication clusters were evaluated. Advanced neoplasm was defi ned as adenoma > 10 mm in size,with > 25% villous features or with high-grade dyspla-sia or cancer.RESULTS:A total of 4623 eligible patients underwent a total colonoscopy. The prevalence of advanced neo-plasia was 13%,with 281 (6%) adenocarcinomas and 342 (7%) advanced adenomas. Sixty-seven percent and 33% of advanced neoplasia were located in the distal and proximal colon,respectively. Of all patients with right-sided advanced neoplasia (n = 228),51% had a normal distal colon,whereas 27% had a syn-chronous distal adenoma. Ten percent of all colono-scopies were performed in asymptomatic patients,7% of whom had advanced neoplasia. In the respective procedure indication clusters,the prevalence of right-sided advanced neoplasia ranged from 11%-57%. CONCLUSION:One out of every 7-8 colonoscopies yielded an advanced colorectal neoplasm. Colonoscopy is warranted for the evaluation of both symptomatic and asymptomatic patients.Jochim S Terhaar sive Droste Mike E Craanen Rene WM van der Hulst Joep F Bartelsman Dick P Bezemer Kim R Cappendijk Gerrit A Meijer Linde M Morsink Pleun Snel Hans ARE Tuynman Roy LJ van Wanrooy Eric IC Wesdorp Chris JJ Mulder 2009World Journal of Gastroenterology2009,15,9:6
3Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors显示文摘AIM:To evaluate systemic treatment choices in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors(PNETs)and provide consensus treatment recommendations.METHODS:Systemic treatment options for pancreatic neuroendocrine tumors have expanded in recent years to include somatostatin analogs,angiogenesis inhibitors,inhibitors of mammalian target of rapamycinand cytotoxic agents.At this time,there is little data to guide treatment selection and sequence.We therefore assembled a panel of expert physicians to evaluate systemic treatment choices and provide consensus treatment recommendations.Treatment appropriateness ratings were collected using the RAND/UCLA modified Delphi process.After studying the literature,a multidisciplinary panel of 10 physicians assessed the appropriateness of various medical treatment scenarios on a 1-9 scale.Ratings were done both before and after an extended discussion of the evidence.Quantitative measurements of agreement were made and consensus statements developed from the second round ratings.RESULTS:Specialties represented were medical and surgical oncology,interventional radiology,and gastroenterology.Panelists had practiced for a mean of15.5 years(range:6-33).Among 202 rated scenarios,disagreement decreased from 13.2%(26 scenarios)before the face-to-face discussion of evidence to 1%(2)after.In the final ratings,46.5%(94 scenarios)were rated inappropriate,21.8%(44)were uncertain,and30.7%(62)were appropriate.Consensus statements from the scenarios included:(1)it is appropriate to use somatostatin analogs as first line therapy in patients with hormonally functional tumors and may be appropriate in patients who are asymptomatic;(2)it is appropriate to use everolimus,sunitinib,or cytotoxic chemotherapy therapy as first line therapy in patients with symptomatic or progressive tumors;and(3)beyond first line,these same agents can be used.In patients with uncontrolled secretory symptoms,octreotide LAR doses can be titrated up to 60 mg every4 wk or up to 40 mg every 3 or 4 wk.CONCLUSION:Using the Delphi process allowed physician experts to systematically obtain a consensus on the appropriateness of a variety of medical therapies in patients with PNETs.Jonathan R Strosberg George A Fisher Al B Benson Lowell B Anthony Bulent Arslan John F Gibbs Edward Greeno Renuka V Iyer Michelle K Kim William J Maples Philip A Philip Edward M Wolin Dasha Cherepanov Michael S Broder 2015World Journal of Gastroenterology2015,21,8:2
4Macrodiversity power control in hierarchical CDMA cellular systems显示文摘KIM J Y GORDON L S IAN F A 2001IEEE Journal on Selected Areas in Commun2001,19,2:2
5Production of dimethylsulfonium propionate (DMSP) and dimethylsulfide (DMS) by a microbial food web显示文摘Belviso S Kim S K Rassoulzadegan F 1990Limnol Oceanogr1990,35,:1
6Excentral cleavage of beta- carotene in vivo in a healthy man显示文摘HO C C de MOURA F F KIM S H 2007Clin Nutr2007,85,3:1
7Direct polymerization of sulfonated poly(arylene ether sulfone) random (statistical) copolymers:candidates for new proton exchange membranes显示文摘WANG F HICKER M KIM Y S 2002J Membr Sci2002,197,:1
8Improved operational stability of polyfluorene-based organic light-emitting diodes with plasma-treated indium-tin-oxide anodes显示文摘KIM J S FRIEND R H CACIALLI F 1999Appl Phys Lett1999,74,21:1
9Characterization of hearing loss in aged type Ⅱ diabetics显示文摘Frisina S T Mapes F Kim S H 2006J Hear Res2006,211,12:1
10Stability kinetics of influenza vaccine coated onto microneedles during drying and storage显示文摘Kim Y C Quan F S Compans R W 2011Pharm Res2011,28,1:1
11Option pricing under stochastic volatility and tempered stable Levy jumps显示文摘Zaevski T S Kim Y S Fabozzi F J 2014International Review of Financial Analysis2014,31,1:1
12Pro- teomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries显示文摘Shiekh F A Charlesworth J E Kim S H 2010Ac- ta Biomaterialia2010,6,10:1
13High performance Nd2Fe14B magnets 显示文摘Kim A S Camp F E 1996J Appl Phys1996,79,08:1
14Immunogenicity of an adenoviral- based middle east respiratory syndrome coronavirus vaccine in balb/c mice显示文摘Kim E Okada K Kenniston T Raj V S A1Hajri M M Farag E A AIHairi F Osterhaus A D Haagmans B L Gambotto A 2014Vaccine2014,32,45:1
15Characteristics of protease from shrimp processing discards 显示文摘Heu M S Kim J S Shahidi F 2003Journal of Food Biochemistry2003,27,:1
16Constraints on the application of the MBT/CBT palaeothermometer in high latitude environments ( Svalbard, Norway) 显示文摘Peterse F Kim J H Schouten S 2009Organic Geochemistry2009,40,:1
17Slinding wear behavior of TiN and CrN coated 2024 aluminum alloy against an A1203 ball显示文摘ZHOU F SUH C M KIM S S 2002Tribology Letters2002,13,3:1
18Vascular relaxation by ethanol extract of Xanthoceras sorbifolia via Akt-and SOCE-eNOS-cGMP pathways显示文摘Jin S N Wen J F Kim H Y 2010J Ethnopharmacol2010,132,:1
19Fabrication and characterization of heteropolyacid(H3PW12O40)/directly polymerized sulfonated poly (arylene ether sulfone) copolymer composite membranes for higher temperature fuel cell applications 显示文摘KIM Y S WANG F HICKER M 2003J Membr Sci2003,212,:1
20A complex of the IL-1 homo-logue IL-lF7b and IL-18-binding protein reduces IL-18 activity显示文摘Bufler P Azam T Gamboni-Robertson F Reznikov LL Ku-mar S Dinarello CA Kim SH 2002Proc Natl Acad Sci USA2002,99,13:1
返回顶部 每页显示:
共55页 首页 上一页 第1页 下一页 末页 /55 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费